Reykjavik, Iceland, May 1, 2008

deCODE genetic Announces First Quarter 2008 Financial Results

Reykjavik, Iceland, April 29, 2008

deCODE Discovers Genetic Variants Influencing Bone Mineral Density

Reykjavik, Iceland, April 27, 2008

deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer

Reykjavik, Iceland, April 25, 2008

deCODE Lauds Federal Legislation To Ban Discrimination on the Basis of Genetic Information

Reykjavik, Iceland, April 24, 2008

deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results

Reykjavik, Iceland, April 6, 2008

deCODE Identifies Novel Regions of the Human Genome that Affect Normal Adult Height

Reykjavik, Iceland, April 2, 2008

A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease

Reykjavik, Iceland, March 25, 2008

deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference

Reykjavik, Iceland, March 16, 2008

deCODE Obesity Study Sheds Light on how Genetics Affects Risk and Onset of Common Diseases

Reykjavik, Iceland, March 14, 2008

deCODE genetics hosts webcast of CEO Kari Stefansson's presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference

Reykjavik, Iceland, March 12, 2008

deCODE genetics Announces Full-year 2007 Financial Results

Reykjavik, Iceland, March 4, 2008

deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results

Reykjavik, Iceland, February 10, 2008

deCODE launches a DNA-based test for assessing risk of prostate cancer on the back of the discovery of new prostate cancer genes

Reykjavik, Iceland, February 7, 2008

deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference

Reykjavik, Iceland, February 7, 2008

deCODE Links Closer Kinship with Reproductive Success

Reykjavik, Iceland, January 31, 2008

deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women

Reykjavik, Iceland, January 9, 2008

Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack

Reykjavik, Iceland, Janury 6, 2008

Not only lipids and inflammation: Insight into a new cause of heart attack and other vascular disease

Reykjavik, Iceland, Janury 4, 2008

deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference

Reykjavik, Iceland, December 19, 2007

deCODE Announces Availability of deCODEme™ Subscription Gift Certificates

Reykjavik, Iceland, November 23, 2007

deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference

Reykjavik, Iceland, November 23, 2007

deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference

Reykjavik, Iceland, November 16, 2007

deCODE Launches deCODEme™

Reykjavik, Iceland, November 5, 2007

deCODE genetics Announces Third Quarter 2007 Financial Results

Reykjavik, Iceland, November 2, 2007

deCODE genetics Showcases DNA-based Diagnostics at American Heart Association Annual Meeting

Reykjavik, Iceland, October 30, 2007

deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results

Reykjavik, Iceland, October 21, 2007

deCODE Discovers Genetic Variants Influencing Skin, Eye and Hair Color

Reykjavik, Iceland, October 11, 2007

deCODE Launches deCODE MI™ - A Test for a Major Genetic Risk Factor for Early-onset Heart Attack

Reykjavik, Iceland, October 9, 2007

deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attck

Reykjavik, Iceland, August 29, 2007

deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference

August 9, 2007

deCODE Discovers Cause of Major Subtype of Glaucoma

Reykjavik, August 1, 2007

deCODE genetics Announces Second Quarter 2007 Financial Results

Reykjavik, July 26, 2007

deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2007 Financial Results

Reykjavik, July 18, 2007

deCODE Gene Discovery Points to New Approach for Treating Major Sleep Disorder

Reykjavik, Iceland, July 1, 2007

deCODE Discovers a Variation in the Sequence of the Genome Conferring Risk of Atrial Fibrillation - Launches deCODE AF™, A Test for the Risk Variant Aimed at the Prevention of Stroke

July 1, 2007

deCODE Discovers Gene Variant that Confers Risk of Prostate Cancer and Protects Against Type 2 Diabetes

Reykjavik, Iceland, June 25, 2007

Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event

Reykjavik, Iceland, June 14, 2007

deCODE Announces Settlement of Lawsuit

Reykjavik, Iceland, June 12, 2007

deCODE Nets $18.4 Million Through Sale-Leaseback of Chicago Facility

May 27, 2007

deCODE Discovers Common Genetic Variants Linked to Increased Risk of Breast Cancer

May 3, 2007

deCODE Identifies Novel Genetic Variant Associated with Increased Risk of Heart Attack

Reykjavik, Iceland, May 1, 2007

deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack

Reykjavik, Iceland, April 30, 2007

deCODE genetics Announces First Quarter 2007 Financial Results

Reykjavik, Iceland, April 26, 2007

deCODE genetics to Webcast Presentation at the 2007 Morgan Stanley Healthcare Unplugged Conference

Reykjavik, Iceland, April 25, 2007

deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2007 Financial Results

Reykjavik, Iceland, April 15, 2007

deCODE Launches deCODE T2™, a Novel DNA-based Test for Assessing Inherited Risk of Type 2 Diabetes

Reykjavik, Iceland, April 1, 2007

deCODE Discovers Second Major Prostate Cancer Risk Variant on Chromosome 8q24

Reykjavik, Iceland, March 14, 2007

deCODE genetics to Webcast Presentation at Lehman Brothers Tenth Annual Global healthcare Conference Results

Reykjavik, Iceland, March 6, 2007

deCODE genetics Announces Full-year 2006 Financial Results

Reykjavik, Iceland, February 28, 2007

deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2006 Financial Results

Reykjavik, Iceland, February 8, 2007

deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference